AMERGE (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the AMERGE drug offered from GlaxoSmithKline LLC. This Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | naratriptan hydrochloride |
| SUBSTANCE NAME: | NARATRIPTAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1998-02-26 |
| END MARKETING DATE: | 0000-00-00 |
AMERGE HUMAN PRESCRIPTION DRUG Details:
| Item Description | AMERGE from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 1998-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0561_6f09204f-5de5-4805-bf9d-7e7d762be454 |
| PRODUCT NDC: | 0173-0561 |
| APPLICATION NUMBER: | NDA020763 |
Other NARATRIPTAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
